Skip to main content
logo
Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.925
+0.145 (5.22%)
Aug 21, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182014 - 2019
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2014 - 2019
Gene Therapeutics
1.00M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapeutics Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182014 - 2019
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2014 - 2019
United States
1.00M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade